163 related articles for article (PubMed ID: 24910450)
1. Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions.
Lieury A; Chanal M; Androdias G; Reynolds R; Cavagna S; Giraudon P; Confavreux C; Nataf S
Glia; 2014 Oct; 62(10):1645-58. PubMed ID: 24910450
[TBL] [Abstract][Full Text] [Related]
2. Demyelination versus remyelination in progressive multiple sclerosis.
Bramow S; Frischer JM; Lassmann H; Koch-Henriksen N; Lucchinetti CF; Sørensen PS; Laursen H
Brain; 2010 Oct; 133(10):2983-98. PubMed ID: 20855416
[TBL] [Abstract][Full Text] [Related]
3. Immunopathology of secondary-progressive multiple sclerosis.
Prineas JW; Kwon EE; Cho ES; Sharer LR; Barnett MH; Oleszak EL; Hoffman B; Morgan BP
Ann Neurol; 2001 Nov; 50(5):646-57. PubMed ID: 11706971
[TBL] [Abstract][Full Text] [Related]
4. Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging.
Gilmore CP; Geurts JJ; Evangelou N; Bot JC; van Schijndel RA; Pouwels PJ; Barkhof F; Bö L
Mult Scler; 2009 Feb; 15(2):180-8. PubMed ID: 18845658
[TBL] [Abstract][Full Text] [Related]
5. Sodium channel expression within chronic multiple sclerosis plaques.
Black JA; Newcombe J; Trapp BD; Waxman SG
J Neuropathol Exp Neurol; 2007 Sep; 66(9):828-37. PubMed ID: 17805013
[TBL] [Abstract][Full Text] [Related]
6. Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease.
Tallantyre EC; Bø L; Al-Rawashdeh O; Owens T; Polman CH; Lowe J; Evangelou N
Brain; 2009 May; 132(Pt 5):1190-9. PubMed ID: 19420101
[TBL] [Abstract][Full Text] [Related]
7. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
[TBL] [Abstract][Full Text] [Related]
8. A Unique TGFB1-Driven Genomic Program Links Astrocytosis, Low-Grade Inflammation and Partial Demyelination in Spinal Cord Periplaques from Progressive Multiple Sclerosis Patients.
Nataf S; Barritault M; Pays L
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28981455
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
Storch MK; Piddlesden S; Haltia M; Iivanainen M; Morgan P; Lassmann H
Ann Neurol; 1998 Apr; 43(4):465-71. PubMed ID: 9546327
[TBL] [Abstract][Full Text] [Related]
10. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
Trapp BD; Vignos M; Dudman J; Chang A; Fisher E; Staugaitis SM; Battapady H; Mork S; Ontaneda D; Jones SE; Fox RJ; Chen J; Nakamura K; Rudick RA
Lancet Neurol; 2018 Oct; 17(10):870-884. PubMed ID: 30143361
[TBL] [Abstract][Full Text] [Related]
11. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions.
Mews I; Bergmann M; Bunkowski S; Gullotta F; Brück W
Mult Scler; 1998 Apr; 4(2):55-62. PubMed ID: 9599334
[TBL] [Abstract][Full Text] [Related]
12. Molecular signature of slowly expanding lesions in progressive multiple sclerosis.
Jäckle K; Zeis T; Schaeren-Wiemers N; Junker A; van der Meer F; Kramann N; Stadelmann C; Brück W
Brain; 2020 Jul; 143(7):2073-2088. PubMed ID: 32577755
[TBL] [Abstract][Full Text] [Related]
13. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord.
Wolswijk G
Brain; 2002 Feb; 125(Pt 2):338-49. PubMed ID: 11844734
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
Henderson AP; Barnett MH; Parratt JD; Prineas JW
Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
[TBL] [Abstract][Full Text] [Related]
15. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
16. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
[TBL] [Abstract][Full Text] [Related]
17. Extensive hippocampal demyelination in multiple sclerosis.
Geurts JJ; Bö L; Roosendaal SD; Hazes T; Daniëls R; Barkhof F; Witter MP; Huitinga I; van der Valk P
J Neuropathol Exp Neurol; 2007 Sep; 66(9):819-27. PubMed ID: 17805012
[TBL] [Abstract][Full Text] [Related]
18. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.
Yanagawa K; Kawachi I; Toyoshima Y; Yokoseki A; Arakawa M; Hasegawa A; Ito T; Kojima N; Koike R; Tanaka K; Kosaka T; Tan CF; Kakita A; Okamoto K; Tsujita M; Sakimura K; Takahashi H; Nishizawa M
Neurology; 2009 Nov; 73(20):1628-37. PubMed ID: 19917985
[TBL] [Abstract][Full Text] [Related]
19. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
[TBL] [Abstract][Full Text] [Related]
20. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
